
Austar Lifesciences Limited
6118.HKHKSEHealthcareMedical - Devices
Latest quote
HK$0.77
+HK$0.035 · +4.76%
6118.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteAustar Lifesciences Limited functions as an investment holding company, delivering integrated engineering and technology solutions to pharmaceutical production facilities and research institutions globally, with a significant presence in Mainland China. Its business activities are structured across six primary divisions: liquid and bioprocessing systems; controlled environment and automated monitoring systems; powder and solid material handling systems; Good Manufacturing Practice (GMP) adherence services; life science expendables; and the brokerage and supply of pharmaceutical machinery. The company's product portfolio is extensive, including systems for pharmaceutical water, liquid preparation, and bioprocessing; powder and solid processing units; clean utility infrastructure; and advanced cleanroom technology. They also supply automated control and monitoring systems, freeze-dryers, sterile filling equipment, and visual inspection apparatus. Furthermore, Austar provides products for pharmaceutical contamination control, aseptic packaging and containment, biosafety and lab animal equipment and consumables, single-use bioprocess components, and offers holistic laboratory setup solutions. Beyond its product offerings, Austar Lifesciences extends a wide array of professional services, such as design and engineering, quality risk management, expert consultation, research and development assistance, process optimization, and digitalization strategies. The company also offers post-sale support, on-site services, system upgrades, facility relocation guidance, and comprehensive asset management. Additionally, it serves as an agent and distributor for pharmaceutical equipment, providing associated assembly and pre-assembly services. Established in 1991, Austar Lifesciences Limited is headquartered in Shanghai, China.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Kwok Keung
- Listed since
- Nov 7, 2014
- Employees
- 1,468
Market position
Day range
Current HK$0.77
52-week range
Current HK$0.77
- Open
- HK$0.75
- Previous close
- HK$0.735
- Volume
- 26K
- 0.41× average
- Average volume
- 63.11K
- Average daily volume
- Market cap
- 394.69M HKD
- Beta
- 0.84
- Market reference 1
- 50-day average
- HK$0.7065
- +8.99% above average
- 200-day average
- HK$0.8172
- -5.77% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 467.78M CNY
- P/E (TTM)
- 10.05×
- P/B (TTM)
- 0.44×
- P/S (TTM)
- 0.22×
- EV / EBITDA
- 6.4×
- Earnings yield
- 8.44%
- Free cash flow yield
- 24.90%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 19.16%
- Operating margin
- 3.54%
- Net margin
- 2.21%
- Return on equity
- 4.11%
- Return on assets
- 1.59%
- Return on invested capital
- 3.06%
Financial health
- Debt / equity
- 0.42×
- Current ratio
- 1.36×
Earnings
- Latest EPS result
- 0.02
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
6118.HK peers
Continue in GoAI
Research 6118.HKresearch.disclaimer





